Arcadia Biosciences, Inc.
RKDA
$1.12
$0.076.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.86M | 5.17M | 5.41M | 5.26M | 5.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.86M | 5.17M | 5.41M | 5.26M | 5.05M |
| Cost of Revenue | 3.11M | 3.09M | 3.26M | 3.07M | 2.86M |
| Gross Profit | 1.75M | 2.09M | 2.15M | 2.19M | 2.18M |
| SG&A Expenses | 7.00M | 8.09M | 8.76M | 9.32M | 9.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.11M | 11.17M | 12.01M | 12.38M | 12.50M |
| Operating Income | -5.25M | -6.00M | -6.61M | -7.13M | -7.46M |
| Income Before Tax | -2.33M | -5.03M | -7.07M | -762.00K | -4.31M |
| Income Tax Expenses | 8.00K | 8.00K | 8.00K | 8.00K | 8.00K |
| Earnings from Continuing Operations | -2.34 | -5.04 | -7.08 | -0.77 | -4.32 |
| Earnings from Discontinued Operations | -- | -27.00K | -457.00K | -1.25M | -2.72M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.34M | -5.07M | -7.54M | -2.02M | -7.04M |
| EBIT | -5.25M | -6.00M | -6.61M | -7.13M | -7.46M |
| EBITDA | -5.22M | -5.95M | -6.55M | -7.05M | -7.34M |
| EPS Basic | -1.71 | -3.71 | -5.52 | -1.48 | -5.16 |
| Normalized Basic EPS | -2.32 | -3.49 | -4.42 | -2.91 | -3.72 |
| EPS Diluted | -1.72 | -3.72 | -5.52 | -1.93 | -5.61 |
| Normalized Diluted EPS | -1.14 | -2.31 | -3.24 | -2.35 | -3.16 |
| Average Basic Shares Outstanding | 5.47M | 5.47M | 5.46M | 5.46M | 5.45M |
| Average Diluted Shares Outstanding | 6.71M | 6.70M | 6.70M | 7.27M | 7.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |